Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NSE - Delayed Quote INR

Eris Lifesciences Limited (ERIS.NS)

Compare
1,274.65
-46.65
(-3.53%)
At close: April 7 at 3:30:02 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
27,239,250
19,912,950
16,618,160
13,261,680
11,926,440
Cost of Revenue
6,695,180
3,876,380
3,570,780
2,608,060
2,418,690
Gross Profit
20,544,070
16,036,570
13,047,380
10,653,620
9,507,750
Operating Expense
14,296,170
11,083,570
8,825,470
6,403,000
5,620,020
Operating Income
6,247,900
4,953,000
4,221,910
4,250,620
3,887,730
Net Non Operating Interest Income Expense
-2,030,310
-777,910
-238,690
18,790
3,100
Pretax Income
4,372,290
4,312,390
4,046,430
4,421,980
3,944,970
Tax Provision
849,050
341,850
304,830
364,090
393,620
Net Income Common Stockholders
3,293,530
3,919,830
3,821,580
4,061,130
3,551,350
Diluted NI Available to Com Stockholders
3,293,530
3,919,830
3,821,580
4,061,130
3,551,350
Basic EPS
24.21
28.82
28.10
29.89
26.16
Diluted EPS
24.18
28.79
28.07
29.88
26.14
Basic Average Shares
136,044.28
136,013.58
135,978.95
135,873.03
135,780.65
Diluted Average Shares
136,230.43
136,168.11
136,168.11
135,914.49
135,883.26
Rent Expense Supplemental
--
32,290
22,200
32,450
21,080
Total Expenses
20,991,350
14,959,950
12,396,250
9,011,060
8,038,710
Net Income from Continuing & Discontinued Operation
3,293,530
3,919,830
3,821,580
4,061,130
3,551,350
Normalized Income
3,239,113.57
3,857,412.02
3,774,627.90
3,930,581.22
3,506,719
Interest Income
--
70,100
22,990
60,980
22,850
Interest Expense
2,100,410
848,010
261,680
41,460
18,020
Net Interest Income
-2,030,310
-777,910
-238,690
18,790
3,100
EBIT
6,472,700
5,160,400
4,308,110
4,463,440
3,962,990
EBITDA
9,387,950
6,986,450
5,478,990
5,110,490
4,392,840
Reconciled Cost of Revenue
6,695,180
3,876,380
3,570,780
2,608,060
2,418,690
Reconciled Depreciation
2,915,250
1,826,050
1,170,880
647,050
429,850
Net Income from Continuing Operation Net Minority Interest
3,293,530
3,919,830
3,821,580
4,061,130
3,551,350
Total Unusual Items Excluding Goodwill
67,530
67,530
50,770
142,210
49,590
Total Unusual Items
67,530
67,530
50,770
142,210
49,590
Normalized EBITDA
9,320,420
6,918,920
5,428,220
4,968,280
4,343,250
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
13,113.57
5,112.02
3,817.90
11,661.22
4,959
3/31/2021 - 6/30/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SAKAR.NS Sakar Healthcare Limited
236.04
-2.56%
 
NOVARTIND.BO Novartis India Limited
786.15
-2.10%
 
INDOCO.NS Indoco Remedies Limited
233.60
-6.25%
 
ALKEM.BO Alkem Laboratories Limited
4,700.00
-2.57%
 
NECLIFE.NS Nectar Lifesciences Limited
22.25
-8.92%
 
MEDICAMEQ.NS Medicamen Biotech Limited
458.15
-8.44%
 
RPGLIFE.NS RPG Life Sciences Limited
1,993.90
-8.36%
 
INNOVACAP.NS Innova Captab Limited
834.20
-4.26%
 
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
202.88
-6.00%
 
VENUSREM.NS Venus Remedies Limited
294.05
-5.66%